Our Company
About Us
Leadership Team
Board of Directors
Advisors
News
Events
Careers
BNCT
History
How it Works
Benefits of BNCT
BNCT Virtual Clinic
Pipeline
Technology
Contact Us
TAE.com
NEW EBOOK
Our Company
About Us
Leadership Team
Board of Directors
Advisors
News
Events
Careers
BNCT
History
How it Works
Benefits of BNCT
BNCT Virtual Clinic
Pipeline
Technology
Contact Us
TAE.com
NEW EBOOK
tae_logo_sq
Home
>
TAE Life Sciences to Develop Groundbreaking Therapy for Difficult-to-Treat Cancers, including Head, Neck and GBM; Announces $40 Million Series A Funding
>
tae_logo_sq
March 9, 2018
Previous Story
TAE Life Sciences to Develop Groundbreaking Therapy for Difficult-to-Treat Cancers, including Head, Neck and GBM; Announces $40 Million Series A Funding